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ABSTRACT 
A suitable alternative strategy for liver transplantation is the use of nanofibrous scaffolds 
together with stem cells. In this study, a random hybrid of poly-L-lactic acid (PLLA) and 
polycaprolactone (PCL) was used as a three-dimensional (3D) culture for hepatocyte-like 
cells (HLCs) differentiation and compared with routine culture (2D). The expression of the 
endodermal marker, FOXA2, was assessed on day 3 and the hepatic markers; albumin 
(ALB), alpha-1 antitrypsin (AAT), and cytokeratin-18 (CK-18) were evaluated on day 18 by 
(qPCR). As well as, albumin, alpha-fetoprotein, and low-density lipoprotein (LDL) uptake 
were evaluated by immunocytochemistry; moreover Periodic Acid-Schiff and Oil red were 
done by cell staining. In addition, alpha-fetoprotein (AFP) and urea production were 
evaluated by chemiluminescence and colorimetric assays. Light and Scanning Electron 
Microscopy (SEM) showed changes in the cells in 2D and 3D models. The gene expression 
of hepatic markers was significantly higher in the three-dimensional cultures. In addition, 
immunocytochemistry and cell staining showed that albumin, alpha-fetoprotein, LDL-uptake, 
Periodic Acid-Schiff, and Oil red were expressed in both cells derived on 2D and 3D. 
Furthermore, the evaluation of alpha-fetoprotein and urea secretion was significantly 
different between 2D and 3D strategies. These findings suggest that functionally cells 
cultured on a PLLA/PCL scaffold may be suitable for cell therapy and regenerative medicine. 
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Introduction 
Liver transplantation is currently the best treatment for patients at the final stage of liver 
failure(Yu et al., 2012), However, the number of donor organs is very limited. Hence, the use 
of novel approaches such as stem cells, especially human induced pluripotent stem cells 
(hiPSCs) and artificial cell engineering for regenerative medicine have been proposed as a 
new alternatives cell therapy to overcome the shortage of transplantable livers. hiPS cells are 
human-specific cells with unlimited pluripotent like-embryonic stem cell properties that they 
are ideal cells for differentiation (Mahboudi et al., 2017), and they may provide a source of 
hepatocyte-like cells (HLCs) that may provide an alternative to transplantation therapy in 
regenerative medicine. Moreover, the properties of nanofibrous scaffolds used in tissue 
engineering are similar to the natural extracellular matrix (ECM) and this subject is vital for 
cell-matrix, cell-cell and cell-scaffold contacts for the regulation of cell growth and 
differentiation process which can be adopted by the body system. Nanofibrous scaffolds are 
synthetic biocompatible scaffolds which have topographic structures that can be fabricated to 
mimic the structures of natural ECM (Mashhadikhan et al., 2015). Preliminary studies have 
used various scaffolds such as polyethersulfone (PES) (Hashemi et al., 2009; Kazemnejad et 
al., 2009; Mahmoodinia Maymand et al., 2017), PLLA (Feng et al., 2010; Ghaedi et al., 
2012) and PCL/collagen/PES (Mahmoodinia Maymand et al., 2017) for hepatocyte 
differentiation. However, these scaffolds have limitations; for example Zhang et al., 2005 
reported that PCL nanofibers need effective hybridization with bioactive molecules (Zhang et 
al., 2005). As well as, PES is a non-biodegradable and suitable polymer requested to repair 
hard tissues like bone and cartilage. Likewise, researchers are less likely to use pure PLLA 
because of poor biocompatibility. Most importantly, scaffolds fabricated of single polymers 
display poor mechanical properties and are not easy to handle (Kazemnejad et al., 2007). 
Until recently, studies have been conducted on non-embryonic-like stem cells. To overcome 
these limitations, many reports have indicated the possible applications of PLLA/PCL blends 
(Chen et al., 2013; Mobarra et al., 2018), and generally, it has been specified that PLLA/PCL 
hybrid fibers are nano-bio degradable, cost-effective, flexible and biocompatible polymers 
that their structure is similar to ECM and important that this polymer is ideal for the 
differentiation of soft tissues (Shakhssalim et al., 2017). Various techniques have emerged for 
the fabrication of nanofibers, But generally, electrospin is most commonly used for the 
fabrication of nanofibers because of low cost, the alter of solution composition and simplicity 
in biological manipulation (Zhang et al., 2007). Also, the use of this process has the potential 
to produce scaffold polymers on a large scale. Following this pattern and the production of 
induced cell-based tissue regeneration, in the present study, to investigate the capacity of 
PCL/PLLA nanofibers to support the successful differentiation of the hiPSCs to HLCs, we 
evaluated the expression of biochemical and molecular liver markers. Under in vitro 
conditions, results showed that 3D hybrid scaffold compared to 2D culture can provide the 
better function of new hepatocytes for hiPS stem cell therapy and regenerative medicine. 
Method and material 
The culture of human induced pluripotent stem cells and embryonic body 
formation  
Culture and expansion of hiPSCs were undertaken as previously described (Mobarra et al., 
2014). These embryonic-like stem cells were seeded on to mouse embryonic fibroblast 
(MEF) feeder layer inactivated with mitomycin-C (Sigma, St. Louis, MO) in Dulbecco's 
Modified Eagle Medium/Nutrient Mixture F-12 (DMEM F-12) enriched with knockout 
serum replacement, 100 µM nonessential amino acids, 2 mM L-glutamine, 100 µM 2-
mercaptoethanol and 4 ng/ml basic fibroblast growth factor (bFGF) (all from Invitrogen). The 
cells were incubated at 370C under 95% humidity and 5% CO2 for embryonic body (EB) 
formation. Aggregated hiPSCs colonies were detached with collagenase IV (Gibco, 15140-
122) and transferred into four-well non-attachment plates containing complete medium 
without bFGF for differentiation. 
The differentiation of hiPSCs to HLCs 
EB cells were subcultured in two groups: group A was expanded on the nanofibrous hybrid 
membrane and the next group was transferred to gelatin-coated tissue culture plate. Briefly, 
to induce endoderm, for one day EBs plated in serum-free RPMI 1640 medium (Gibco, 
11875119) supplemented with B27 (Gibco, 0080085SA) and 100 ng/ml activin A (Stemgent 
03-001). Insulin-transferrin-selenium (ITS, Gibco, 41400045) was added to this medium for 
the following two days. The medium was replaced with Hepatocyte Culture Medium (HCM, 
Lonza, CC-3198) enriched with 2% fetal bovine serum (FBS), 20 ng/ml hepatocyte growth 
factor (HGF, R&D, 294-HGN-005) and 20 ng/ml fibroblast growth factor-4 (FGF-4, R&D, 
235-F4-025) to produce pre-mature hepatocytes. The medium was changed every 2 days. 
After 8 days of culture, to maturate the hepatic cells, cultured cells were treated with 5% 
FBS, 20 ng/ml oncostatin M (OSM, R&D, 295-OM-010) plus 0.1 μM dexamethasone (Dex, 
R&D, 2749/10), 1% non-essential amino acids and L-glutamine that added to HCM on 
gelatin-coated plates and PLLA/PCL nanofibrous scaffold membrane for additional 9 days. In 
parallel, we added hiPSCs media for the control group. 
PLLA/PCL fabrication and oxygen treatment 
Random nanofibrous PLLA/PCL scaffold was fabricated via electrospinning in the Stem Cell 
Technology Research Center. Briefly, PLLA 4% and PCL 8% powder dissolved in 
chloroform, then N, N-dimethylformamide (DMF) as the second solvent was added and the 
mixture was homogenized in the needle. After that, the collector was placed at a distance of 
15 cm from the needle. A polymer solution with a high voltage potential (20 kV) was forced 
through the needle and collected as nanofibers on the rotating cylinder. To increase the 
hydrophilic feature, the random membrane was treated with pure oxygen in a plasma 
generator under low 44 KHz frequency in cylindrical quartz reactor (Diener Electronics, 
Germany) at 0.4 mbar pressure and then the glow discharge was performed for 3 min. 
Nanofibrous sheets were punched into discs with a diameter conforming to the 4-well plates, 
afterward were sterilized for 30 min and put overnight in the complete culture medium. 
RNA extraction and Real-Time PCR processing 
Total RNA was extracted on days 3 and 18 in 2D and three-dimensional cultures, as well as a 
control group using TRIzol Reagent (Gibco, 15596018). For the reverse transcriptase 
reaction, approximately 3 μg of total RNA was used with the revert aid first strand cDNA 
synthesis Kit (Fermentas, k1621) and oligo dT primers according to the manufacturer’s 
instructions. The cDNA was amplified by using Takara SYBR Premix ExTaq Master Mix 
(RR820A). Gene expression levels were quantified by the ABI Light Cycler (ABI step one) 
and analyzed by rest 2009. Target gene expression values were normalized to the signal get 
from housekeeping gene beta-Actin mRNA (ActB) and calibrated to the hiPSCs. Primers and 
product lengths are presented in Table 1. 
Immunocytochemistry staining 
Cells were rinsed twice with PBS and fixed with 4% paraformaldehyde (Sigma, 30525-89-4) 
at room temperature (RT) for 20 min. Afterward, the cells were washed and permeabilized 
with 3% Triton X-100 in phosphate-buffered saline (PBS). Then, the fixed cells were 
incubated with primary-mouse antibodies against human alpha-fetoprotein (AFP, 1:200, 
R&D, MAB1368), and mouse monoclonal anti-Albumin (ALB, 1: 200, R&D, MAB1455) 
overnight at 4°C. On the second day, the cells were washed 3 times with PBS-Tween 20 
(0.1%) and incubated with the PE-conjugated as a secondary antibody, goat anti-mouse 
(1:100; R&D, F0102B) for 45 min at 37 °C in the dark. Subsequently, these matured cells 
were washed with PBS-%0.1Tween, 3× for 5 min. The nuclei were counterstained with 4´, 6-
diamidino-2-phenylindole [(DAPI) (1 μg/ml)] (Sigma, 28718-90-3). All images were taken 
with a fluorescence microscope (Nikon; Japan).  
Imaging with Scanning Electron Microscopy (SEM) 
HiPS cell-derived hepatocyte-like cells on the surface of PLLA/PCL polymer were washed 
three times with PBS and fixed in 2.5% v/v glutaraldehyde for 20 min and dehydrated in a 
serial of graded ethanol (20% -100%). Subsequently, the cells were dried overnight and 
sputter-coated with gold before viewing under the SEM (MED010; Baltec). Top images were 
viewed at an accelerating voltage of 20 Kv using a Hitachi Model-4500 SEM. 
Cellular Low-Density Lipoprotein (LDL) uptake assay 
Low-Density Lipoprotein (LDL) uptake in matured cells was measured by using the DiI-Ac-
LDL staining kit according to the manufacturer’s protocol (Biomedical Technologies, BT-
904) (Mobarra et al., 2014).  
Periodic Acid-Schiff (PAS) stain for glycogen content 
Briefly, HLCs-derived cells in the third week were fixed with 4% paraformaldehyde for 20 
min at room temperature and then washed with PBS. Fixed cells were oxidized in 1% 
Periodic Acid (Sigma, 10450-60-9) for 5 min and rinsed 3 times in distilled water. Afterward, 
induced cells were treated with Schiff’s reagent (Sigma, 3952016) for 10-15 minutes. 
Subsequently, they washed in low pressure running water for 5 minutes and assessed under a 
light microscope (Olympus, Japan). 
 
 
 
Oil red 
HLCs-derived cells were fixed with 4% paraformaldehyde for 20 min at room temperature 
and then washed with PBS and incubated for 45 min with oil red reagent. After that, the cells 
were washed with running water and analyzed by a light microscope (Olympus, Japan). 
Biochemical assays for AFP and Urea production 
Conditioned media was collected on days zero, 3, 9 and 18 after the start of differentiation in 
2D and 3D cultures. The conditioned media was assayed for Aalpha-fetoprotein (AFP) 
production using a chemiluminescence immunoassay kit (Diasorin.UK). Moreover, the urea 
cell concentration was measured by a Colorimetric Assay Kit (Pars Azmun, 1400029) 
according to the manufacturer's recommendations. Undifferentiated hiPSCs media were used 
as controls. The data were normalized based on defined cell number. 
Statistical Method 
Kolmogorov-Smirnov test was used to check the normality of the data. In the case of normal 
data, the mean and standard deviation were used to describe the data. To comparison of 
mRNA expression in iPS and Endoderm on day 7, the independent t-test was used between 
the two groups of OCT-4 and SOX-17. To compare ALB, AAT, and CK-18, the t-test was 
used between 2D and 3D groups. As well as, to comparison of AFP in iPS, t-test was used for 
2D and 3D groups on day 3, day 9, and day 18. Also, t-test was used to compare urea in iPS 
between 2D and 3D groups on days 3, 9 and 18. The significance level was taken as *P<0.05. 
 
 
 
 
Results 
Scaffold characterization 
Hybrid PLLA/PCL scaffold membrane was synthesized by electrospinning and treated by 
oxygen plasma generator. The morphological characteristics, size and the porous structures of 
the scaffold were evaluated by SEM micrographs (figure 1A, 1B).  
hiPSCs culture and embryonic body formation 
The hiPSCs exhibited a tightly packed and flat morphology with sharp edges, large nuclei 
and limited cytoplasm (Figure 2A). After detaching and transferring in suspension culture 
medium, the hiPSCs clones formed ovoid structures known as embryonic bodies (EBs) 
(Figure 2B). 
Morphological changes of hiPSCs to HLCs on gelatin-coated plates (2D) 
and scaffold plates (3D) 
Using two-dimensional cultures, the embryonic bodies were seeded into 4-well tissue culture 
plates for 18 days. As shown in figure 3A, the hiPS cells were attached to the tissue culture 
plates and began to differentiate into the definitive endoderm by the 3rd day. In the second 
stage, these endoderm cells changed morphology to the less dense and spindle-like shape that 
these are the sign of pre-maturity (Figure 3B). However, the combination of recombinant 
growth factors in final stage resulted in morphological change, with significantly flattened 
and binucleated cells with large cytoplasm. The features that are a marker for new 
hepatocytes (Figure 3C). In three dimensional cultures, SEM analysis showed that hiPS cells 
before differentiation were well attached and penetrated the surfaces of the hybrid membrane 
(Figure 1C). Viability and the rate of hiPSCs proliferation and differentiation on PLLA/PCL 
nanofiabrous scaffold indicated that matured cells resembled the typical flattened shapes of 
hepatocytes (Figure 1D). These morphological findings indicate the maturation of hepatic 
cells. 
Endoderm and hepatocyte gene expression 
At the beginning and three days after the start of the process, the mRNA of attached cells 
derived from the EBs were assessed by quantitative PCR. The gene expression of the 
endoderm marker, FOXA2, was increased significantly after three days, whereas the 
expression of pluripotent transcription factor OCT-4 was reduced (P < 0.05). These results 
indicate that the hiPSCs could be efficiently differentiated into endoderm in vitro (Figure 
4A). As well as, confirming the differentiation status, we found that the gene expression of 
the hepatocytes specific markers albumin (ALB), alpha-1 antitrypsin (AAT) and cytokeratin-
18 (CK18) were increased in 18 days after culturing on the hybrid membrane. A significant 
up-regulation in the mRNA expression of markers mentioned above was observed in mature 
cells that had differentiated when grown on PLLA/PCL, compared to those grown in 2D 
culture which was differentiated on the gelatin-coated plate (p < 0.05) (Figure 4B). Overall, 
these results indicated that synthetic PLLA/PCL scaffold can enhance and improve the 
efficiency of hiPSCs differentiation to hepatocyte-like cells. 
Immunofluorescence and cell staining 
Immunostaining analysis was conducted to test whether cell-specific differentiation markers, 
such as Aalbumin and alpha-fetoprotein were secreted on 18th days of differentiation and 
whether this differed by culture conditions. We also examined the ability of the differentiated 
cells to uptake LDL (Figure 5), and their glycogen content. There was a strong positive 
staining in HLCs (Figure 6). These results support hepatocyte maturation. As shown in 
Figure 5, in both 2D and 3D, albumin and AFP, as well as LDL-uptake appeared more 
rapidly in the number of positive cells for hepatic markers in 3D than 2D cultured cells. 
Positive staining by Oil Red O and for glycogen granules was detected in the cytoplasm of 
differentiated HLCs on two-dimensional culture and also those grown on the nanofibrous 
scaffold (Figure 6). 
Alpha-fetoprotein and urea secretion quantity in HLCs 
We also investigated the production of other biochemical hepatic markers, alpha-fetoprotein 
and urea on day 18. The maximum expression of AFP was shown in pre-mature hepatocytes 
on day 9 before starting the final stage of maturation. A significant difference in production 
was observed in the pre-matured cells that differentiated on the PLLA/PCL in comparison to 
the cells in 2D culture (Figure 7A), also urea production continuously increased until day 18 
(Figure 7B). This increase in differentiation and then production was more evident in 3D than 
two-dimensional (p<0.05). Briefly, the control group did not secrete any hepatic markers 
(data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Discussion  
There has been a significant interest in the use of nanofibers in tissue engineering for stem 
cells. It appeares that the combination of iPSCs and nanofibrous scaffolds have several 
beneficial effects and potential in the treatment of liver disease (Kazemnejad et al., 2007). A 
large number of studies have reported that the use of hiPSCs is the best choice for cell 
transplantation and regenerative medicine in patients with a non-functioning liver (Kehtari et 
al., 2018; Khademi et al., 2017; Starokozhko et al., 2018). Aloysious and Nair have reported 
that using 3D culture for the differentiation of various cell types is better than two-
dimensional (2D) culture for the differentiation of cells (Aloysious and Nair, 2014), because 
nanofibrous scaffolds mimic three dimensional structures of the natural microenvironment 
extracellular matrix (ECM) which enhances effective differentiation (Stendahl et al., 2009). 
Therefore, nanofibrous scaffolds are increasingly being used for tissue engineering. 
Preliminary studies have used various scaffolds such as PES (Hashemi et al., 2009; 
Kazemnejad et al., 2009), PLLA (Feng et al., 2010; Ghaedi et al., 2012) and 
PCL/collagen/PES (Mahmoodinia Maymand et al., 2017) for hepatocyte differentiation. In 
the current study, our results demonstrated that hepatic markers are markedly expressed 
better in hybrid scaffolds than single nanofibrous scaffolds (Mahmoodinia Maymand et al., 
2018). L-form of poly-lactic acid (PLLA), is a polyester approved by FDA and L-lactic acid 
is the product of this scaffolds degradation which is harmless for the body(Islami et al., 
2018). Poly (ε-caprolactone) (PCL) is a bioresorbable, biocompatible and inexpensive 
nanofiber, having native tissue-like properties that generally used for tissue regeneration. The 
hybrid scaffold has several advantages over a single polymer (Shakhssalim et al., 2017).  
Many studies show that stem cells can differentiate into hepatocyte like-cells by using single 
nanofibrous scaffolds on gelatin-coated plates or nanofibrous scaffolds, but so far, there have 
been few studies performed on their effects on the differentiation of hiPSCs to HLCs on the 
surface of nano-scaffold hybrids. Therefore, in this study, we used hiPSCs as the source of 
stem cells and PLLA/PCL hybrid membrane as a new scaffold was used to differentiate into 
the hepatocyte-like cell. We found that: (1) PLLA/PCL polymer supports the attachment, 
proliferation, and differentiation of hiPSCs (2) the successful generation of hepatic-like cells 
from hiPSCs on the hybrid scaffold and (3) the newly derived cells expressed higher levels of 
liver markers than cells differentiated on gelatin-coated plates and single nanofibrous 
scaffolds. Our results are consistent with those of Mahmoodinia Maymand et al 
(Mahmoodinia Maymand et al., 2018) in using SEM, we found that the formed cells 
aggregated, adhered and penetrated to the scaffold. Our SEM results showed a highly porous 
and nonwoven architecture that mimics ECM structure, likewise Kinasiewicz et al 
(Kinasiewicz et al., 2008). It was observed that PES membranes support the growth of 
hepatic cells in 3D culture. This result was also found in our study. Similar to the results of 
Kazemnejad et al (Kazemnejad et al., 2007) as shown in figure 1, the artificial scaffold 
formed by the PLLA/PCL hybrid, not only provided a suitable support for hiPSCs 
proliferation but also allowed the cells to maintain their stability and flexibility during the 
differentiation process. Our qPCR result showed that hiPSCs expressed the pluripotent stem 
cell marker OCT-4 and the levels of this protein marker fell after three days of differentiation 
in endoderm lineage. We also examined the ability of hiPSCs to differentiate into endoderm 
lineages. As shown in figure 4, endodermic marker FOXA2 successfully was expressed in 
day 3. This result was consistent with our preliminary reports(Jaafarpour et al., 2018; 
Jaafarpour et al., 2016) and inconsistent with the study of Mahmoodinia Maymand et al 
(Mahmoodinia Maymand et al., 2017) that reported the mRNA expression of FOXA2 was 7 
fold lower than in our report, this discrepancy may be due to the numbers of days to 
differentiate into endoderm lineage which in our study was 3 days and study Mahmoodinia 
Maymand et al (Mahmoodinia Maymand et al., 2017) was 5 days. Moreover, the up-regulation 
of albumin, CK18, and AAT specific mRNA further confirm the functionality of hepatocyte-
like cells in 3D culture which were significantly more highly expressed than cells induced in 
two-dimensional cultures. Ghaedi et al (Ghaedi et al., 2012)  in a line with our result reported 
that the expression of albumin and CK-18 were significantly higher in hMSCs cultured on the 
PLLA nanofibrous scaffold than on cultured in the 2D plate. But the expression level of 
albumin and CK-18 in cells cultured on PLLA scaffold in her study was significantly lower 
than our result which cells differentiated on PLLA/PCL membrane, this inconsistency may be 
due to the type of stem cell and the nanofiber used. Additionally, Mahmoodinia Maymand et 
al (Mahmoodinia Maymand et al., 2017) have demonstrated that the expression level of 
marker ALB in hepatocyte differentiated on PES is lower than our result that is 5 folds. These 
results show that hiPSCs may be better differentiated on hybrid scaffold than single PES 
nanofibrous membrane. In our study and the report of Kazemnejad et al(Kazemnejad et al., 
2007), in the final day of differentiation (Figure 5), Immunohistochemical staining was 
positive for protein biochemical markers Albumin and AFP in the large fraction of derived 
hepatocytes in two and three-dimensional cultures. Obviously, the formation of mature 
hepatocyte-like cells was further confirmed by the positive staining of Oil red and Periodic 
Acid Schiff in both 2D and 3D (Figure. 6). As well as, secretory markers AFP and urea were 
investigated as additional markers for hepatocyte-specific function at protein and nitrogen 
levels in the differentiated cells (Figure 7). The expression of AFP protein in the middle day 
of differentiation process was dramatically increased, but decreased after 9 days of culture; 
this reduction in three dimensional culture medium was markedly increased than cells that 
derived in gelatin plates. This pattern suggests the presence of hepatic progenitors such as 
oval-shaped cells. As well as, urea production continued to be expressed and increased up to 
18 days of culture, especially in cells that cultured and differentiated on PLLA/PCL 
membrane. This model is agreed with N. Lin1 (Lin et al., 2010) that showed urea production 
was increased in bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on 
the nanofibrous scaffold. Our study has limitations, although we analyzed the potency of 
hiPS Cell-derived hepatocyte-Like cells on random PLLA/PCL scaffold, the high cost and 
time do not allow to our team to check the potency of PLLA and PCL differentiation 
separately and also PLLA/PCL aligned scaffold. Also, further experiments are needed to 
evaluate the intracellular structures and obtain excellent and desirable liver cells for in vivo 
regenerative medicine. 
Conclusion 
We have fabricated a new hybrid PLLA/PCL scaffold membrane and have used this as an 
approach for the differentiation of hiPSCs to bio artificial hepatocyte-like cells that appears to 
be highly suitable for this purpose for the first time. This finding suggests that functional 
matured induced cells on PLLA/PCL scaffold can be used as a successful method for the soft 
tissue engineering of the liver, tissue engineering therapy, and regenerative medicine. 
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Legends 
Figure1: Scanning electron microscopy of A, B) unseeded hybrid random PLLA/PCL scaffolds C) 
hiPSCs-seeded before differentiation on 3D nanofibrous D) Differentiated hiPSCs to HLC on 
PLLA/PCL membrane.  Scale bars a ia 10 μm.and b, c and d are 100 μm.  
Figure 2. Phase contrast microscopy images of A) hiPSC colonies on MEFs inactivated feeders B) 
embryonic bodies (EBs) EBs in hanging culture medium. Scale bars are 100 μm. 
Figure 3. Morphological changes of hiPSCs during differentiation on gelatin-coated palates A) began 
to assemble hiPSCs to endoderm lineage B) pre-matured induced cells C) differentiated hepatocyte-
like cells. Scale bars are 100 μm. 
Figure 4. Quantitative transcriptional analysis of gene markers. A) pluripotent and endodermal 
markers at the beginning and after three days of starting the process. B) Relative hepatic gene 
expression in end-stage derived IPCs. * Significance was defined as P < 0.05 and values represent 
means ± SD.  
Figure 5. Immunocytochemistry staining ALB and AFP protein as well as LDL-uptake the main 
hepatic markers in end-stage derived cells on gelatin-coated plated (2D) and hybrid scaffold (3D). 
Nuclei were stained with DAPI.  Data are presented as mean ± SEM. Scale bars are 100 μm. 
Figure 6. Staining analysis of matured HLCs include glycogen (PAS) and lipid storage (Oil red) in 
two (A) and three (B) dimensional culture. Scale bars are 100 μm. 
Figure 7. A) Alpha-fetoprotein and B) Urea production by hepatocytes at developmental stages. * 
Significance was defined as P < 0.05 and values represent means ± SD. 
 
 
 
 
  
 
 
 
 
 
  
  
 
 
 
 
 
  
 
 
 
 
